EMZOTAMIG
UNII WQN6EJ3AH6

Substance Identification & Data

This profile provides standardized clinical and technical data for Emzotamig, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WQN6EJ3AH6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3037572-57-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
WQN6EJ3AH6
CAS Registry Number
3037572-57-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
EMZOTAMIG
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C224734
National Cancer Institute reference terminology for clinical and research data.
INN ID
13697
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Emzotamig. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

EMZOTAMIG

Common Names & Synonyms

EMZOTAMIG [INN]
IMMUNOGLOBULIN (VH-(H-GAMMA1)_ V-LAMBDA-10MER-V-KAPPA-10MER-C-KAPPA))_G1(H-CH2-CH3), ANTI-(HOMO SAPIENS NCR1 (NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1, NKP46, NKP46, NK CELL-ACTIVATING RECEPTOR, LY94, CD335)), ANTI-(HOMO SAPIENS TNFRSF17 (TUMOR NECROSIS FACTOR (TNF) RECEPTOR SUPERFAMILY MEMBER 17, B CELL MATURATION ANTIGEN, BCMA, TNFRSF13A, CD269)), HUMANIZED MONOCLONAL ANTIBODY, BISPECIFIC, BIVALENT (EMZOTAMIG)

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus